| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1ed7d7fa047577218d4c7ab42e47f9a4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5929f2d6f4dba84be8dd3a8ba633db12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_57ff08f73781433fe9797c26dbb6a84b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_01e1cace93e42454c7099592e4430d2c |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-705 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705 |
| filingDate |
2001-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_142db75df46327cd674914c500a78e45
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c0be58c122b43576e0f2f4bf76f9002a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cddf553da6261dfe8b8c6a73ff1ba4d3 |
| publicationDate |
2002-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-0246394-A1 |
| titleOfInvention |
Novel g protein-coupled receptor protein and dna thereof |
| abstract |
It is intended to provide a novel protein which is useful in, for example, screening an agonist/an antagonist. More particularly, a novel protein or its salt; a DNA encoding this protein; a method of determining a ligand to this protein; a method of screening a compound altering the binding properties of the ligand to the protein and a screening kit therefor; a compound obtained by this screening method or its salt; and the like. The above protein or the DNA encoding the same are usable in, for example: (1) determining a ligand to the above protein; (2) preventives and/or remedies for diseases in association with the hypofunciton of the protein; and (3) screening a compound (an agonist, an antagonist, etc.) altering the binding properties of the protein to the ligand. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005100987-A1 |
| priorityDate |
2000-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |